Celldex Therapeutics, Inc. Payments to Acquire Marketable Securities
Celldex Therapeutics, Inc. (CLDX) reported Payments to Acquire Marketable Securities of $462.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-06
- Celldex Therapeutics, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $402.85M, a 229.51% increase year-over-year.
- Celldex Therapeutics, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $59.61M, a 60.74% decline year-over-year.
- Celldex Therapeutics, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $54.79M, a 57.58% decline year-over-year.
- Celldex Therapeutics, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $55.63M, a 44.40% decline year-over-year.
- Celldex Therapeutics, Inc. payments to acquire marketable securities for fiscal 2025 was $384.50M, a 51.32% decline from fiscal 2024.
- Celldex Therapeutics, Inc. payments to acquire marketable securities for fiscal 2024 was $789.92M, a 86.06% increase from fiscal 2023.
- Celldex Therapeutics, Inc. payments to acquire marketable securities for fiscal 2023 was $424.56M, a 124.68% increase from fiscal 2022.
- Celldex Therapeutics, Inc. payments to acquire marketable securities for fiscal 2022 was $188.97M, a 51.53% decline from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $402.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $462.46M 10-Q · filed 2026-08-06 | $517.25M derived: sum of 3 quarters · filed 2026-08-06 | $572.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $59.61M 10-Q · filed 2026-05-07 | $114.40M derived: sum of 2 quarters · filed 2026-05-07 | $170.03M derived: sum of 3 quarters · filed 2026-05-07 | $292.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $54.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $110.42M derived: sum of 2 quarters · filed 2026-02-25 | $232.68M derived: sum of 3 quarters · filed 2026-08-06 | $384.50M 10-K · filed 2026-02-25 |
| 2025-09-30 | $55.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $177.89M derived: sum of 2 quarters · filed 2026-08-06 | $329.71M 10-Q · filed 2025-11-10 | $458.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $122.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $274.08M 10-Q · filed 2026-08-06 | $403.26M derived: sum of 3 quarters · filed 2026-08-06 | $503.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $151.82M 10-Q · filed 2026-05-07 | $281.00M derived: sum of 2 quarters · filed 2026-05-07 | $381.06M derived: sum of 3 quarters · filed 2026-05-07 | $549.57M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $129.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $229.24M derived: sum of 2 quarters · filed 2026-02-25 | $397.75M derived: sum of 3 quarters · filed 2026-02-25 | $789.92M 10-K · filed 2026-02-25 |
| 2024-09-30 | $100.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $268.57M derived: sum of 2 quarters · filed 2025-11-10 | $660.75M 10-Q · filed 2025-11-10 | $902.13M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $168.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $560.69M 10-Q · filed 2025-08-07 | $802.08M derived: sum of 3 quarters · filed 2026-02-25 | $829.83M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $392.18M 10-Q · filed 2025-05-08 | $633.57M derived: sum of 2 quarters · filed 2026-02-25 | $661.32M derived: sum of 3 quarters · filed 2026-02-25 | $742.89M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $241.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $269.14M derived: sum of 2 quarters · filed 2026-02-25 | $350.71M derived: sum of 3 quarters · filed 2026-02-25 | $424.56M 10-K · filed 2026-02-25 |
| 2023-09-30 | $27.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $109.33M derived: sum of 2 quarters · filed 2024-11-06 | $183.17M 10-Q · filed 2024-11-06 | $239.52M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $81.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $155.42M 10-Q · filed 2024-08-08 | $211.77M derived: sum of 3 quarters · filed 2025-02-27 | $274.54M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $73.85M 10-Q · filed 2024-05-06 | $130.20M derived: sum of 2 quarters · filed 2025-02-27 | $192.96M derived: sum of 3 quarters · filed 2025-02-27 | $245.92M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $56.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $119.12M derived: sum of 2 quarters · filed 2025-02-27 | $172.07M derived: sum of 3 quarters · filed 2025-02-27 | $188.97M 10-K · filed 2025-02-27 |
| 2022-09-30 | $62.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $115.72M derived: sum of 2 quarters · filed 2023-11-02 | $132.61M 10-Q · filed 2023-11-02 | $197.15M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $52.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $69.85M 10-Q · filed 2023-08-08 | $134.39M derived: sum of 3 quarters · filed 2024-02-26 | $373.99M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $16.89M 10-Q · filed 2023-05-04 | $81.43M derived: sum of 2 quarters · filed 2024-02-26 | $321.03M derived: sum of 3 quarters · filed 2024-02-26 | $372.80M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $64.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $304.14M derived: sum of 2 quarters · filed 2024-02-26 | $355.91M derived: sum of 3 quarters · filed 2024-02-26 | $389.88M 10-K · filed 2024-02-26 |
| 2021-09-30 | $239.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $291.37M derived: sum of 2 quarters · filed 2022-11-09 | $325.34M 10-Q · filed 2022-11-09 | $362.27M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $51.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $85.74M 10-Q · filed 2022-08-08 | $122.67M derived: sum of 3 quarters · filed 2023-02-28 | $173.62M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $33.97M 10-Q · filed 2022-05-05 | $70.90M derived: sum of 2 quarters · filed 2023-02-28 | $121.85M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | $36.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $87.88M derived: sum of 2 quarters · filed 2023-02-28 | $220.32M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $50.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $183.39M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $132.44M 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $18.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $36.82M derived: sum of 2 quarters · filed 2022-02-28 | $73.98M derived: sum of 3 quarters · filed 2022-02-28 | $95.38M 10-K · filed 2022-02-28 |
| 2019-09-30 | $18.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $55.61M derived: sum of 2 quarters · filed 2020-11-05 | $77.01M 10-Q · filed 2020-11-05 | $96.64M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | $37.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $58.56M 10-Q · filed 2020-08-06 | $78.19M derived: sum of 3 quarters · filed 2021-03-29 | $152.84M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | $21.40M 10-Q · filed 2020-05-06 | $41.03M derived: sum of 2 quarters · filed 2021-03-29 | $115.68M derived: sum of 3 quarters · filed 2021-03-29 | $161.47M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | $19.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $94.28M derived: sum of 2 quarters · filed 2021-03-29 | $140.06M derived: sum of 3 quarters · filed 2021-03-29 | $171.18M 10-K · filed 2021-03-29 |
| 2018-09-30 | $74.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $120.44M derived: sum of 2 quarters · filed 2019-11-12 | $151.56M 10-Q · filed 2019-11-12 | $200.30M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $45.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $76.90M 10-Q · filed 2019-08-07 | $125.65M derived: sum of 3 quarters · filed 2020-03-26 | $155.91M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | $31.12M 10-Q · filed 2019-05-07 | $79.86M derived: sum of 2 quarters · filed 2020-03-26 | $110.13M derived: sum of 3 quarters · filed 2020-03-26 | $151.14M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | $48.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $79.01M derived: sum of 2 quarters · filed 2020-03-26 | $120.02M derived: sum of 3 quarters · filed 2020-03-26 | $170.98M 10-K · filed 2020-03-26 |
| 2017-09-30 | $30.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $71.27M derived: sum of 2 quarters · filed 2018-11-07 | $122.23M 10-Q · filed 2018-11-07 | $146.28M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $41.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $91.97M 10-Q · filed 2018-08-08 | $116.02M derived: sum of 3 quarters · filed 2019-03-07 | $145.84M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $50.96M 10-Q · filed 2018-05-10 | $75.01M derived: sum of 2 quarters · filed 2019-03-07 | $104.83M derived: sum of 3 quarters · filed 2019-03-07 | $176.03M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $24.05M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $53.87M derived: sum of 2 quarters · filed 2019-03-07 | $125.06M derived: sum of 3 quarters · filed 2019-03-07 | $173.93M 10-K · filed 2019-03-07 |
| 2016-09-30 | $29.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $101.02M derived: sum of 2 quarters · filed 2017-11-07 | $149.88M 10-Q · filed 2017-11-07 | $162.47M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $71.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $120.05M 10-Q · filed 2017-08-08 | $132.64M derived: sum of 3 quarters · filed 2018-03-07 | $162.02M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $48.86M 10-Q · filed 2017-05-09 | $61.45M derived: sum of 2 quarters · filed 2018-03-07 | $90.83M derived: sum of 3 quarters · filed 2018-03-07 | $134.72M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $12.59M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $41.97M derived: sum of 2 quarters · filed 2018-03-07 | $85.86M derived: sum of 3 quarters · filed 2018-03-07 | $206.41M 10-K · filed 2018-03-07 |
| 2015-09-30 | $29.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $73.27M derived: sum of 2 quarters · filed 2016-11-07 | $193.81M 10-Q · filed 2016-11-07 | $195.97M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $43.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $164.43M 10-Q · filed 2016-08-08 | $166.59M derived: sum of 3 quarters · filed 2017-03-14 | $186.53M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $120.54M 10-Q · filed 2016-05-05 | $122.70M derived: sum of 2 quarters · filed 2017-03-14 | $142.63M derived: sum of 3 quarters · filed 2017-03-14 | $156.44M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $22.09M derived: sum of 2 quarters · filed 2017-03-14 | $35.90M derived: sum of 3 quarters · filed 2017-03-14 | $148.31M 10-K · filed 2017-03-14 |
| 2014-09-30 | $19.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $33.74M derived: sum of 2 quarters · filed 2015-11-05 | $146.16M 10-Q · filed 2015-11-05 | $165.88M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $13.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $126.22M 10-Q · filed 2015-08-10 | $145.94M derived: sum of 3 quarters · filed 2016-02-25 | $149.50M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $112.42M 10-Q · filed 2015-04-29 | $132.13M derived: sum of 2 quarters · filed 2016-02-25 | $135.69M derived: sum of 3 quarters · filed 2016-02-25 | $170.72M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $19.72M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $23.27M derived: sum of 2 quarters · filed 2016-02-25 | $58.31M derived: sum of 3 quarters · filed 2016-02-25 | $112.12M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $38.59M derived: sum of 2 quarters · filed 2014-11-05 | $92.40M 10-Q · filed 2014-11-05 | $103.75M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $35.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $88.84M 10-Q · filed 2014-08-07 | $100.20M derived: sum of 3 quarters · filed 2015-02-24 | $118.72M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $53.81M 10-Q · filed 2014-05-01 | $65.16M derived: sum of 2 quarters · filed 2015-02-24 | $83.68M derived: sum of 3 quarters · filed 2015-02-24 | $89.68M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $29.87M derived: sum of 2 quarters · filed 2015-02-24 | $35.87M derived: sum of 3 quarters · filed 2015-02-24 | $69.25M 10-K · filed 2015-02-24 |
| 2012-09-30 | $18.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $24.51M derived: sum of 2 quarters · filed 2013-11-08 | $57.90M 10-Q · filed 2013-11-08 | $62.40M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $39.38M 10-Q · filed 2013-08-06 | $43.88M derived: sum of 3 quarters · filed 2014-03-03 | $53.37M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $33.39M 10-Q · filed 2013-05-03 | $37.89M derived: sum of 2 quarters · filed 2014-03-03 | $47.38M derived: sum of 3 quarters · filed 2014-03-03 | $82.86M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $13.99M derived: sum of 2 quarters · filed 2014-03-03 | $49.47M derived: sum of 3 quarters · filed 2014-03-03 | $52.72M 10-K · filed 2014-03-03 |
| 2011-09-30 | $9.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $44.97M derived: sum of 2 quarters · filed 2012-11-02 | $48.22M 10-Q · filed 2012-11-02 | $52.47M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | $35.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $38.73M 10-Q · filed 2012-08-09 | $42.98M derived: sum of 3 quarters · filed 2013-03-08 | $51.37M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | $3.25M 10-Q · filed 2012-05-04 | $7.50M derived: sum of 2 quarters · filed 2013-03-08 | $15.89M derived: sum of 3 quarters · filed 2013-03-08 | |
| 2010-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $12.65M derived: sum of 2 quarters · filed 2013-03-08 | $56.52M 10-K · filed 2013-03-08 | |
| 2010-09-30 | $8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $52.27M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $43.88M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $9.56M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |